Efficacy of Tumor Vaccines and Cellular Immunotherapies in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis [REVIEW ARTICLE]
Conclusion
Tumor vaccines and cellular immunotherapies enhanced OS and PFS in NSCLC. Cellular immunotherapy was found to be more effective than tumor vaccination. These findings have implications for future studies investigating combination immunotherapy in NSCLC.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Dammeijer, Lievense, Veerman, Hoogsteden, Hegmans, Arends, Aerts Tags: Chemotherapy, Combined Modality REVIEW ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Study | Vaccines